c/o Zobec Services Limited
HP House
21 Laffan Street
Hamilton HM09

Tel: 441-294-2471
Email: bjackson@clarienbank.com
BSX Currency: USD
ISIN: US472145AE19
CUSIP: 472145AE1


Jazz Investments I Limited (the “Issuer”) is a Bermuda exempted company limited by shares incorporated on July 19, 2013 and are resident in Ireland for tax purposes, and are a wholly-owned finance subsidiary of the parent Jazz Pharmaceuticals.

Jazz Pharmaceuticals is a public limited company formed under the laws of Ireland (registered number 399192) and is the ultimate parent company to the Jazz Pharmaceuticals group of companies. Jazz Pharmaceuticals is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. Jazz Pharmaceuticals has a diverse portfolio of products and product candidates, with a focus in the areas of sleep and hematology/oncology.

Jazz Investments I Limited., US$1,000,000,000 2.000% Exchangeable Senior Notes due June 15, 2026;  are issued pursuant to Rule 144A under the United States Securities Act 1933 as amended (the “Securities Act”). The Notes will be fully and unconditionally guaranteed, on a senior unsecured basis, by the Parent.





Disclaimer and Privacy Policy    Complaints Policy

Copyright © 2024 by Bermuda Stock Exchange. All rights reserved!

Questions or requests for information can be emailed to  info@bsx.com